Literature DB >> 3108446

Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.

R Korngold, J Sprent.   

Abstract

Highly purified populations of L3T4+ and Lyt-2+ T cell subsets were compared for their capacity to cause lethal GVHD in six different H-2-compatible, multiple minor histocompatibility antigen-different murine strain combinations. In four of these combinations (C3H.SW----B6, DBA/2----B10.D2, B10.BR----CBA, and B10.S----SJL), lethal GVHD appeared to be caused almost entirely by Lyt-2+ cells; the injection of L3T4+ cells resulted in low mortality even when these cells were presensitized to the recipient antigens. In the remaining two combinations (B10.D2----DBA/2 and B10.D2----BALB/c), L3T4+ T cells were able to cause a high incidence of GVHD and were more potent than the Lyt-2+ cells. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108446      PMCID: PMC2188361          DOI: 10.1084/jem.165.6.1552

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Non-H-2 antigens can induce high GVH mortality in adult recipients of normal cells.

Authors:  O Halle-Pannenko; L L Pritchard; R Motta; G Mathé
Journal:  Biomedicine       Date:  1978-11

2.  T lymphocyte responses to non-H-2 histocompatibility antigens. I. Role of Ly-1+2+ T cells as cytotoxic effectors and requirement for Ly-1+2+ T cells for optimal generation of cytotoxic effectors.

Authors:  P J Wettstein; J A Frelinger
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

Review 3.  H-2 restricted cytolytic and noncytolytic T cell clones: isolation, specificity and functional analysis.

Authors:  H von Boehmer; W Haas
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

4.  Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.

Authors:  D A Vallera; C C Soderling; J H Kersey
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

5.  Antigen-driven helper cell-independent cloned cytolytic T lymphocytes.

Authors:  M B Widmer; F H Bach
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

6.  Antigenic competition between minor (non-H-2) histocompatibility antigens.

Authors:  L L Johnson; D W Bailey; L E Mobraaten
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  Kinetics of the anti-recipient cytotoxic cell response of mice with minor histocompatibility antigen graft-vs-host disease.

Authors:  B L Hamilton; R Parkman
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.

Authors:  B L Hamilton; M J Bevan; R Parkman
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

9.  Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.

Authors:  R Korngold; J Sprent
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

10.  Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex.

Authors:  R Korngold; J Sprent
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  40 in total

Review 1.  T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection.

Authors:  H Auchincloss; T Mayer; R Ghobrial; H J Winn
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Treg-mediated prolonged survival of skin allografts without immunosuppression.

Authors:  Nina Pilat; Mario Wiletel; Anna M Weijler; Romy Steiner; Benedikt Mahr; Joanna Warren; Theresa M Corpuz; Thomas Wekerle; Kylie E Webster; Jonathan Sprent
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-13       Impact factor: 11.205

3.  Memory CD4+ T cells do not induce graft-versus-host disease.

Authors:  Britt E Anderson; Jennifer McNiff; Jun Yan; Hester Doyle; Mark Mamula; Mark J Shlomchik; Warren D Shlomchik
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

4.  A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivo.

Authors:  P G Schlegel; R Aharoni; Y Chen; J Chen; D Teitelbaum; R Arnon; M Sela; N J Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 5.  Murine models of chronic graft-versus-host disease: insights and unresolved issues.

Authors:  Yu-Waye Chu; Ronald E Gress
Journal:  Biol Blood Marrow Transplant       Date:  2008-02-13       Impact factor: 5.742

Review 6.  Mouse models of bone marrow transplantation.

Authors:  Pavan Reddy; Robert Negrin; Geoffrey R Hill
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

7.  A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation.

Authors:  K Riesner; M Kalupa; Y Shi; S Elezkurtaj; O Penack
Journal:  Bone Marrow Transplant       Date:  2015-11-23       Impact factor: 5.483

8.  Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model.

Authors:  Stephen C Jones; George F Murphy; Thea M Friedman; Robert Korngold
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

9.  Unraveling graft-versus-host disease and graft-versus-leukemia responses using TCR Vβ spectratype analysis in a murine bone marrow transplantation model.

Authors:  Stacey L Fanning; Jenny Zilberberg; Johann Stein; Kristin Vazzana; Stephanie A Berger; Robert Korngold; Thea M Friedman
Journal:  J Immunol       Date:  2012-11-30       Impact factor: 5.422

Review 10.  Target cells in graft-versus-host disease: implications for cancer therapy.

Authors:  George F Murphy
Journal:  Clin Rev Allergy Immunol       Date:  2007-08-14       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.